1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Life Science Cloud Computing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porters Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Life Science Cloud Computing Market, by Service Model
8.1.1. Software-as-a-Service (SaaS)
8.1.1.1. Market Revenue and Forecast
8.1.2. Platform-as-a-Service (PaaS)
8.1.2.1. Market Revenue and Forecast
8.1.3. Infrastructure-as-a-Service (IaaS)
8.1.3.1. Market Revenue and Forecast
9.1. Life Science Cloud Computing Market, by Deployment Model
9.1.1. Public Cloud
9.1.1.1. Market Revenue and Forecast
9.1.2. Private Cloud
9.1.2.1. Market Revenue and Forecast
9.1.3. Hybrid Cloud
9.1.3.1. Market Revenue and Forecast
10.1. Life Science Cloud Computing Market, by Application
10.1.1. R&D and Drug Discovery
10.1.1.1. Market Revenue and Forecast
10.1.2. Clinical Trials & eClinical Solutions
10.1.2.1. Market Revenue and Forecast
10.1.3. Manufacturing & Supply Chain Management
10.1.3.1. Market Revenue and Forecast
10.1.4. Quality Management & Compliance
10.1.4.1. Market Revenue and Forecast
10.1.5. Commercial, Sales & Marketing Analytics
10.1.5.1. Market Revenue and Forecast
10.1.6. Real-World Evidence (RWE) & Data Platforms
10.1.6.1. Market Revenue and Forecast
10.1.7. Data Storage & Backup
10.1.7.1. Market Revenue and Forecast
11.1. Life Science Cloud Computing Market, by End-User
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Biotechnology Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Contract Research Organizations (CROs)
11.1.3.1. Market Revenue and Forecast
11.1.4. Contract Development & Manufacturing Organizations (CDMOs/CMOs)
11.1.4.1. Market Revenue and Forecast
11.1.5. Medical Device Manufacturers
11.1.5.1. Market Revenue and Forecast
12.1. Life Science Cloud Computing Market, by Enterprise Size
12.1.1. Large Enterprises
12.1.1.1. Market Revenue and Forecast
12.1.2. Medium Enterprises
12.1.2.1. Market Revenue and Forecast
12.1.3. Small & Emerging Biopharma
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Service Model
13.1.2. Market Revenue and Forecast, by Deployment Model
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by End-User
13.1.5. Market Revenue and Forecast, by Enterprise Size
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Service Model
13.1.6.2. Market Revenue and Forecast, by Deployment Model
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by End-User
13.1.6.5. Market Revenue and Forecast, by Enterprise Size
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Service Model
13.1.7.2. Market Revenue and Forecast, by Deployment Model
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by End-User
13.1.7.5. Market Revenue and Forecast, by Enterprise Size
13.2. Europe
13.2.1. Market Revenue and Forecast, by Service Model
13.2.2. Market Revenue and Forecast, by Deployment Model
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by End-User
13.2.5. Market Revenue and Forecast, by Enterprise Size
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Service Model
13.2.6.2. Market Revenue and Forecast, by Deployment Model
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by End-User
13.2.8. Market Revenue and Forecast, by Enterprise Size
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Service Model
13.2.9.2. Market Revenue and Forecast, by Deployment Model
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by End-User
13.2.11. Market Revenue and Forecast, by Enterprise Size
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Service Model
13.2.12.2. Market Revenue and Forecast, by Deployment Model
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by End-User
13.2.13. Market Revenue and Forecast, by Enterprise Size
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Service Model
13.2.14.2. Market Revenue and Forecast, by Deployment Model
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by End-User
13.2.15. Market Revenue and Forecast, by Enterprise Size
13.3. APAC
13.3.1. Market Revenue and Forecast, by Service Model
13.3.2. Market Revenue and Forecast, by Deployment Model
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by End-User
13.3.5. Market Revenue and Forecast, by Enterprise Size
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Service Model
13.3.6.2. Market Revenue and Forecast, by Deployment Model
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by End-User
13.3.7. Market Revenue and Forecast, by Enterprise Size
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Service Model
13.3.8.2. Market Revenue and Forecast, by Deployment Model
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by End-User
13.3.9. Market Revenue and Forecast, by Enterprise Size
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Service Model
13.3.10.2. Market Revenue and Forecast, by Deployment Model
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by End-User
13.3.10.5. Market Revenue and Forecast, by Enterprise Size
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Service Model
13.3.11.2. Market Revenue and Forecast, by Deployment Model
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by End-User
13.3.11.5. Market Revenue and Forecast, by Enterprise Size
13.4. MEA
13.4.1. Market Revenue and Forecast, by Service Model
13.4.2. Market Revenue and Forecast, by Deployment Model
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by End-User
13.4.5. Market Revenue and Forecast, by Enterprise Size
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Service Model
13.4.6.2. Market Revenue and Forecast, by Deployment Model
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by End-User
13.4.7. Market Revenue and Forecast, by Enterprise Size
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Service Model
13.4.8.2. Market Revenue and Forecast, by Deployment Model
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by End-User
13.4.9. Market Revenue and Forecast, by Enterprise Size
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Service Model
13.4.10.2. Market Revenue and Forecast, by Deployment Model
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by End-User
13.4.10.5. Market Revenue and Forecast, by Enterprise Size
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Service Model
13.4.11.2. Market Revenue and Forecast, by Deployment Model
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by End-User
13.4.11.5. Market Revenue and Forecast, by Enterprise Size
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Service Model
13.5.2. Market Revenue and Forecast, by Deployment Model
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by End-User
13.5.5. Market Revenue and Forecast, by Enterprise Size
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Service Model
13.5.6.2. Market Revenue and Forecast, by Deployment Model
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by End-User
13.5.7. Market Revenue and Forecast, by Enterprise Size
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Service Model
13.5.8.2. Market Revenue and Forecast, by Deployment Model
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by End-User
13.5.8.5. Market Revenue and Forecast, by Enterprise Size
14.1. Defibtech LLC
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Imricor Medical Systems Inc
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. MRI Interventions Inc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Cardiac Science Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Schiller AG
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Acutus Medical Inc
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. MicroPort CRM
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Shree Pacetronix Ltd.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Abbott
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Abbott
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
